Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Name: Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
SKU: 2560
Price: 30.00 USD
Availability: InStock

$30.00

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

By Charles B. Nemeroff, MD, PhD

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 37 Supplement No. 1 Tags: anxiety-disorders, charles-b-nemeroff, depression, of-mood-and-anxiety-disorders, paroxetine, paroxetine-cr, selective-serotonin-reuptake-inhibitors

Description

Description

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

By Charles B. Nemeroff, MD, PhD

006-007_PB-SuppSpr03_Intro

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Description

Gender-Specific Differences in Depression and Treatment Response

Strategies for Treatment-Resistant Depression

Paroxetine Treatment of Depression in Late Life

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Description

Related products

Gender-Specific Differences in Depression and Treatment Response

Strategies for Treatment-Resistant Depression

Paroxetine Treatment of Depression in Late Life

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?